The processing of pro-insulin involves:
Removal of C-peptide
Insulin is a vital hormone produced by the pancreas that helps regulate blood sugar levels. However, insulin is not initially made in its final, active form. It is first synthesized as a precursor protein called pro-insulin. The processing of pro-insulin is a crucial step in creating functional insulin.
Pro-insulin is a single polypeptide chain. It is structured in a way that allows it to fold correctly and form the necessary disulfide bonds that are present in the mature insulin molecule. The structure of pro-insulin consists of three distinct regions:
The B chain and the A chain are the parts that will eventually form the mature insulin molecule. The C-peptide connects the C-terminus of the B chain to the N-terminus of the A chain.
Here is a simplified representation of the structure:
\(\text{B-chain} - \text{C-peptide} - \text{A-chain}\)
The conversion of pro-insulin to mature, active insulin takes place within the secretory granules of the beta cells in the pancreas. This processing involves specific enzymatic cleavages. The main event in this process is the removal of the C-peptide.
Enzymes called prohormone convertases (specifically PC1/3 and PC2) and carboxypeptidase E act on pro-insulin. They cut the polypeptide chain at specific points, releasing the C-peptide from between the B chain and the A chain.
\(\text{Pro-insulin} \xrightarrow{\text{Enzymatic cleavage}} \text{Insulin} + \text{C-peptide}\)
Once the C-peptide is removed, the A chain and the B chain remain linked together by disulfide bonds, forming the structure of mature, active insulin.
The presence of the C-peptide in pro-insulin is important for ensuring that the A and B chains fold correctly and that the appropriate disulfide bonds form during the protein's synthesis and maturation in the endoplasmic reticulum and Golgi apparatus. After folding and disulfide bond formation are complete, the C-peptide is no longer needed and is cleaved off.
Let's look at the given options in the context of pro-insulin processing:
Therefore, the processing of pro-insulin primarily involves the removal of the C-peptide.
| Feature | Pro-insulin | Insulin |
|---|---|---|
| Structure | Single polypeptide chain (B-C-A) | Two chains (A and B) linked by disulfide bonds |
| Presence of C-peptide | Yes | No (removed during processing) |
| Biological Activity | Minimal or no activity | Biologically active |
| Location of Processing | Secretory granules of pancreatic beta cells | N/A (is the mature form) |
| Concept | Description | Relevance to Pro-insulin Processing |
|---|---|---|
| Pro-insulin | Precursor protein to insulin. Single polypeptide chain with B, C, and A segments. | The molecule that undergoes processing. |
| C-peptide | Connecting peptide segment within pro-insulin. | Removed during processing to yield insulin. |
| Enzymatic Cleavage | Cutting of the protein chain by specific enzymes (e.g., prohormone convertases). | The mechanism by which the C-peptide is removed. |
| Disulfide Bonds | Covalent bonds between cysteine residues that link the A and B chains in mature insulin. | Form within pro-insulin, and the removal of the C-peptide allows the A and B chains to remain linked by these bonds. |
| Pancreatic Beta Cells | Cells in the islets of Langerhans in the pancreas that produce insulin. | Where pro-insulin is synthesized and processed. |
Although the C-peptide is removed during insulin processing, it is not just waste. It is released into the bloodstream along with insulin and can be measured. C-peptide levels are often used as an indicator of how much insulin the pancreas is producing endogenously, which is particularly useful in managing diabetes.
Mature insulin's primary function is to facilitate the uptake of glucose from the blood into cells (like muscle and fat cells) for energy or storage. It also affects metabolism in the liver and other tissues. Problems with insulin production or action lead to diabetes mellitus.
Understanding the processing of pro-insulin is essential for comprehending how functional insulin is generated in the body.
Which of the following statements is not correct for Restriction enzymes?
Given below are two statements:
Statement I: In a bioreactor, small volumes of cultures are developed in which useful bio-products are produced.
Statement II: In downstream processing, the products formulated with suitable preservatives are ready for marketing without testing of their quality.
In the light of the above statements, choose the correct answer from the options given below:
A thermostable DNA polymerase is isolated from:
Which one of the following is not a process of DNA recombinant technology?
Downstream processing method involves: